Walgreens buyout marks largest healthcare take-private in years amid PE slowdown
Private equity dealmaking in healthcare services slumped in Q1 2025, with estimated deal volume hitting its lowest point since the 2020 pandemic crash. Still, major developments—like Sycamore Partners’ $10 billion take-private of Walgreens Boots Alliance and a spate of PE exits—signal shifting strategies amid economic headwinds and market volatility. Despite persistent challenges, segments like home-based care and musculoskeletal health are gaining traction, and market dislocation may spur deal flow as sellers capitulate on valuation. Read our latest analyst note for a closer look at sector performance, standout deals, and how changing market conditions are reshaping PE dealmaking in healthcare.